Adicet Bio, Inc. ( ACET) - Key Metrics
ACET Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2025Q1 | ? | ? | ? | ? |
ACET Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | ? |
| 2025Q1 | ? | ? |
ACET Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -29.42% | ? |
| 2025Q4 | -36.02% | ? |
| 2025Q3 | -30.52% | ? |
| 2025Q2 | -48.02% | ? |
| 2025Q1 | -39.11% | ? |
ACET
Price: $8.10
52 week price:
Payout Ratio Range:
Earnings Per Share: -13.87 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 400300
Ebitda: 12.8 millionMarket Capitalization: 77.5 million